Related references
Note: Only part of the references are listed.A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells
Shiyang Shen et al.
NATURE NANOTECHNOLOGY (2021)
Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells
Yunsheng Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
Dejan Vidovic et al.
CELL DEATH AND DIFFERENTIATION (2020)
TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment
Sherona R. Sirkisoon et al.
ONCOGENE (2020)
A Multi-action PtIVConjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells
Hana Kostrhunova et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Pre-activation with TLR7 in combination with thioridazine and loratadine promotes tumoricidal T-cell activity in colorectal cancer
Xiaotan Lin et al.
ANTI-CANCER DRUGS (2020)
Autophagy in Osteosarcoma Cancer Stem Cells Is a Critical Process which Can Be Targeted by the Antipsychotic Drug Thioridazine
Olivier Camuzard et al.
CANCERS (2020)
Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
Vibha Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Thioridazine Enhances P62-Mediated Autophagy and Apoptosis Through Wnt/-Catenin Signaling Pathway in Glioma Cells
Cheng-Wei Chu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Recent therapeutic trends and promising targets in triple negative breast cancer
Soo-Yeon Hwang et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Thioridazine Sensitizes Cisplatin Against Chemoresistant Human Lung and Ovary Cancer Cells
Guanhua Qian et al.
DNA AND CELL BIOLOGY (2019)
Cancer stem cell (CSC) resistance drivers
Masoud Najafi et al.
LIFE SCIENCES (2019)
Cocktail Strategy Based on Spatio-Temporally Controlled Nano Device Improves Therapy of Breast Cancer
Tianqun Lang et al.
ADVANCED MATERIALS (2019)
Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics
Rayana L. Bighetti-Trevisan et al.
STEM CELLS INTERNATIONAL (2019)
Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide
Tor-Christian Johannessen et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Biophysical Phenotyping and Modulation of ALDH plus Inflammatory Breast Cancer Stem-Like Cells
Weiqiang Chen et al.
SMALL (2019)
Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity
Junling Liu et al.
JOURNAL OF PATHOLOGY (2018)
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results
Oleg Gluz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results
Oleg Gluz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Andrew Tutt et al.
NATURE MEDICINE (2018)
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Aurelie S. Cazet et al.
NATURE COMMUNICATIONS (2018)
Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2
Matthew Tegowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Association between Thioridazine Use and Cancer Risk in Adult Patients with Schizophrenia-A Population-Based Study
Cheng-Chen Chang et al.
PSYCHIATRY INVESTIGATION (2018)
A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia
Lili Aslostovar et al.
BLOOD ADVANCES (2018)
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Priyanka Sharma et al.
CLINICAL CANCER RESEARCH (2017)
Thioridazine elicits potent antitumor effects in colorectal cancer stem cells
Chen Zhang et al.
ONCOLOGY REPORTS (2017)
Dopamine receptor D2 is correlated with gastric cancer prognosis
Jiasheng Mu et al.
ONCOLOGY LETTERS (2017)
Thioridazine has potent antitumor effects on lung cancer stem-like cells
Jiani Shen et al.
ONCOLOGY LETTERS (2017)
The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine
Gabriella Spengler et al.
ANTICANCER RESEARCH (2016)
Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy
Hayley J. Paholak et al.
BIOMATERIALS (2016)
Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting
Yangyang Hu et al.
CANCER RESEARCH (2016)
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial
Pin Zhang et al.
ONCOTARGET (2016)
Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine
Haiying Yue et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
Tomonori Tanei et al.
BREAST CANCER RESEARCH (2016)
Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells
Siyuan Wang et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Breast cancer stem cells: Multiple capacities in tumor metastasis
Shao-Qing Geng et al.
CANCER LETTERS (2014)
Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+Cancer Stem Cells
Su He Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer
Jiasheng Mu et al.
ONCOLOGY REPORTS (2014)
A Phase II Trial of Docetaxel and Carboplatin Administered Every 2 Weeks as Preoperative Therapy for Stage II or III Breast Cancer NCCTG Study N0338
Vivek Roy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells
Sokbom Kang et al.
APOPTOSIS (2012)
Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells
Eleftherios Sachlos et al.
CELL (2012)
Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient
Leonard Amaral et al.
PHARMACEUTICALS (2012)
Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Carmen Visus et al.
CLINICAL CANCER RESEARCH (2011)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
Share Paper
